Chris LU,Shou-Ih HU,Michaela KNEISSEL,Christine HALLEUX
申请号:
US13779102
公开号:
US20130164284A1
申请日:
2013.02.27
申请国别(地区):
US
年份:
2013
代理人:
摘要:
The present invention relates to the use of modulators of the sclerostin: sclerostin-binding-partner interaction for the treatment, amelioration, and diagnosis of sclerostin-related disorders, e.g., osteoporosis and sclerosteosis, and sclerostin-related disorders, e.g., cancers and cardiovascular disorders. The invention also relates to the use of sclerostin-binding-partner mimetics for the treatment, amelioration, and diagnosis of sclerostin-related disorders. Assays for the identification of modulators of the sclerostin: sclerostin-binding-partner interaction, as well as the resulting signaling, are also provided.